Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Evaluating the impact of new pediatric brain tumor classifications

Key clinical point: Molecular characterization of pediatric neuronal/glioneuronal tumors has improved in recent years.

Major finding: Molecular characterization provides additional diagnostic and treatment targets.

Study details: Review of multiple studies informing updated World Health Organization classifications.

Disclosures: Dr. Jones has no relevant financial relationships to disclose.


Jones DTW et al. CNS-ICNA 2020, Symposium: Neuro-oncology.